Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04343404
What this trial is testing

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Who this might be right for
Respiratory Distress Syndrome
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Large-scale testing (Phase 3)Study completedNCT04320615
What this trial is testing

Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 452
Not applicableStudy completedNCT04649658
What this trial is testing

Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support

Who this might be right for
Covid19
University of Modena and Reggio Emilia 93
Not applicableStudy completedNCT05476835
What this trial is testing

Effect of Pulmonary Rehabilitation Program on Post Hospitalization Severe COVID- 19 Patients

Who this might be right for
Post COVID-19 Condition
Fayoum University Hospital 100
Not applicableUnknownNCT04375176
What this trial is testing

Monocytes and NK Cells Activity in Covid-19 Patients

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2Immunomodulation
Università degli Studi dell'Insubria 150
Testing effectiveness (Phase 2)UnknownNCT04457726
What this trial is testing

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 18
Large-scale testing (Phase 3)UnknownNCT04886362
What this trial is testing

Ivermectina Colombia (IVERCOL)

Who this might be right for
COVID-19 Pneumonia
Ayudas Diagnosticas Sura S.A.S 966
Large-scale testing (Phase 3)WithdrawnNCT05157269
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Testing effectiveness (Phase 2)Ended earlyNCT04409873
What this trial is testing

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

Who this might be right for
COVID-19SARS-CoV 2Severe Acute Respiratory Syndrome Coronavirus 2+3 more
University of California, San Francisco 54
Early research (Phase 1)UnknownNCT04443270
What this trial is testing

Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients

Who this might be right for
COVID-19
CMN "20 de Noviembre" 200
Testing effectiveness (Phase 2)UnknownNCT04395456
What this trial is testing

The C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)

Who this might be right for
Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Amyndas Pharmaceuticals S.A. 144
Testing effectiveness (Phase 2)UnknownNCT04470531
What this trial is testing

Role of Co-trimoxazole in Severe COVID-19 Patients

Who this might be right for
Covid19Severe COVID-19 Patients
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 94
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Not applicableUnknownNCT04456036
What this trial is testing

Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care

Who this might be right for
COVID-19
Università Politecnica delle Marche 100
Early research (Phase 1)UnknownNCT05212532
What this trial is testing

A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress Syndrome
EOM Pharmaceuticals 40
Not applicableStudy completedNCT04667936
What this trial is testing

Evaluation of Sedation in COVID-19 ARDS

Who this might be right for
Prone PositionSevere Acute Respiratory Syndrome Coronavirus 2Hypnotics and Sedatives+1 more
Goethe University 114
Large-scale testing (Phase 3)Study completedNCT04324463
What this trial is testing

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial

Who this might be right for
CoronavirusSevere Acute Respiratory Syndrome
Population Health Research Institute 6,667
Not applicableStudy completedNCT05092698
What this trial is testing

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19

Who this might be right for
SARS-CoV2 Infection
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 110
Not applicableUnknownNCT04944823
What this trial is testing

Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)

Who this might be right for
Covid19SARS-CoV Infection
Universidad de la Sabana 50
Next Page